{"basic_info": {"ticker": "9926", "exchange": "XHKG", "bloomberg_ticker": "9926 HK Equity", "name": "AKESO INC", "industry": "Biotechnology", "name_chinese_simplified": "康方生物", "period": "2020", "market_value": 29711409152, "total_income": 0, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 0, "business_income_over_total_income": NaN}, {"shariah_compliance": "unknown", "income": 0, "business_income_over_total_income": NaN}], "details": [{"business_activity_cn": "来自许可费收入的收入", "business_activity_en": "Revenue from license fee revenues", "income": 0, "business_income_over_total_income": NaN, "shariah_compliance": "compliant"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": NaN, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.004910003887919597, "shariah_compliance": "compliant", "amount_over_market_value": 0.004910003887919597}]}